• Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022

  • FIT stimulates market diversification with renewed subsidy

    Thursday December 1st 2022

  • Biotalys creates Scientific Advisory Committee with leading experts

    Thursday December 1st 2022

  • argenx enters into agreement to acquire priority review voucher

    Wednesday November 30th 2022

  • Monkeys not Donkeys, QbD Group’s life science marketing and communication agency, strengthens its team

    Monday November 28th 2022

  • Ghent start-up Protealis accelerates local soybean development

    Friday November 25th 2022

  • VIB researchers identify a new way of supporting and sensitizing immunotherapy in cancer patients

    Friday November 25th 2022

  • Oxurion further improves THR-149 patent position

    Thursday November 24th 2022

  • Your news here?

  • Pathomation releases an updated version PMA.transfer to easily manipulate whole slide images in digital pathology and virtual microscopy

    Tuesday November 22nd 2022

  • Nathalie Draux succeeds Philippe Draux as CEO of Quality Assistance

    Tuesday November 22nd 2022

  • argenx announces U.S. FDA acceptance of biologics license application for subcutaneous efgartigimod in generalized myasthenia gravis with priority review

    Tuesday November 22nd 2022

Strategic Partners